800-845-6913
Tuteur & Associates, LLC | Knowledge is Power.
October 25, 2007
October 2007 Leverkusen, Germany and West Haven, Connecticut, USA. – Today Bayer announced new guidance to physicians and health care providers regarding the use of Trasylol® (aprotinin injection) in patients at an increased risk of blood loss and blood transfusion undergoing coronary artery bypass graft (CABG) surgery with cardiopulmonary bypass (CPB). Continue reading, ‘10-25-2007 | Bayer Issues Additional Guidance to Physicians on Trasylol® (aprotinin injection).’